Go to:
Logótipo
Você está em: Start > Publications > View > Activation of adenosine receptors improves renal antioxidant status in diabetic Wistar but not SHR rats
Map of Premises
Principal
Publication

Activation of adenosine receptors improves renal antioxidant status in diabetic Wistar but not SHR rats

Title
Activation of adenosine receptors improves renal antioxidant status in diabetic Wistar but not SHR rats
Type
Article in International Scientific Journal
Year
2014
Authors
Daniela Patinha
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Joana Afonso
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Sousa, T
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Albino Teixeira, A
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 119
Pages: 10-18
ISSN: 0300-9734
Scientific classification
FOS: Medical and Health sciences > Clinical medicine
Other information
Authenticus ID: P-009-5AQ
Abstract (EN): Background. Diabetes and hypertension independently contribute to renal injury, and the major mechanisms involved are increased reactive oxygen species (ROS) bioavailability and renin-angiotensin system (RAS) activation. We investigated the role of adenosine in controlling ROS production and RAS activation associated with renal dysfunction in hypertension and diabetes. Methods. Fourteen days after induction of diabetes with streptozotocin in 12-week-old male Wistar and spontaneously hypertensive (SHR) rats, animals were treated during 7 days with 2-chloroadenosine (CADO group, 5 mg/kg/d), a stable analogue of adenosine, or underwent a sham operation procedure. At the end of the study (day 21), intra-arterial systolic blood pressure (SBP) was measured, and 24-h urine and plasma samples and renal tissue were collected. Results. CADO treatment decreased the plasma glucose concentration and glucose and protein excretion by more than 30% in both strains. CADO treatment decreased SBP in diabetic SHR rats (143 +/- 8 versus 114 +/- 4 mmHg, p < 0.05), but not in diabetic Wistar rats. The hypotensive effect of CADO was associated to a similar to 70% increase in plasma angiotensinogen (AGT) concentration and a similar to 50% decrease in urinary AGT excretion. CADO also caused a decrease in medullary and cortical hydrogen peroxide production of about 40%, which was associated with a proportional increase in glutathione peroxidase (GPx) activity in diabetic Wistar but not in diabetic SHR animals. Conclusions. These results suggest that activation of adenosine receptors improves renal antioxidant capacity in diabetic Wistar but not SHR rats, although it improves glucose metabolism in both strains. Furthermore, activation of adenosine receptors does not seem to be directly influencing AGT production.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 9
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Diabetes-induced increase of renal medullary hydrogen peroxide and urinary angiotensinogen is similar in normotensive and hypertensive rats (2014)
Article in International Scientific Journal
Daniela Patinha; Joana Afonso; Sousa, T; Manuela Morato; Albino Teixeira, A

Of the same journal

What do people know about fertility?: a systematic review on fertility awareness and its associated factors (2018)
Article in International Scientific Journal
Juliana Pedro; Tânia Brandão; Lone Schmidt; Maria Emília Costa; Mariana Veloso Martins
Recommend this page Top
Copyright 1996-2025 © Faculdade de Medicina Dentária da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-20 at 22:28:19 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book